MedPath

ACIDOPHILUS LACTOBACILLUS

Acidophilus Lactobacillus Oral Capsule

Approved
Approval ID

b17b6e92-93ac-4184-86ef-2f79e50d3aac

Product Type

DIETARY SUPPLEMENT

Effective Date

Sep 5, 2025

Manufacturers
FDA

Krewe Pharma, LLC

DUNS: 139887329

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ACIDOPHILUS LACTOBACILLUS

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code87021-100
Product Classification
G
Generic Name
ACIDOPHILUS LACTOBACILLUS
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 5, 2025
FDA Product Classification

INGREDIENTS (1)

LACTOBACILLUS ACIDOPHILUSActive
Quantity: 10000000000 [CFU] in 1 1
Code: 1PRR1V42V5
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/22/2025

PACKAGING:

Label

HEALTH CLAIM SECTION

LOINC: 69719-3Updated: 9/22/2025

HEALTH CLAIM:

Acidophilus Lactobacillus Oral Capsule

Supp Facts

STATEMENT OF IDENTITY SECTION

LOINC: 69718-5Updated: 9/5/2025

DESCRIPTION:

Acidophilus Lactobacillus Oral Capsules are clear capsules dispensed in plastic bottles of 30 ct.

87021-0100-30

Reserved for Professional Recommendation

This listed product is not a National Drug Code, but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.

Manufactured for:

Krewe Pharma

New Port Richey, FL 34652

WARNINGS SECTION

LOINC: 34071-1Updated: 9/5/2025

WARNINGS AND PRECAUTIONS:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

As with any supplement, if you are pregnant, nursing, taking medication, or have a medical condition, ask a health professional before taking this product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 9/5/2025

PRECAUTIONS:

CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

PRECAUTIONS
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

ADVERSE REACTIONS
Allergic sensitizations have been reported following oral administration of folic acid. Consult your physician immediately if adverse side effects occur.

KEEP OUT OF THE REACH OF CHILDREN.

SAFE HANDLING WARNING SECTION

LOINC: 50741-8Updated: 9/5/2025

STORAGE:

Store at 20° - 25° C (68° - 77° F); excursions permitted to 15°-30°C (59°-86°F)[See USP Controlled Room Tempature].

Store in the Refrigerator after opening. DO NOT FREEZE.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 9/10/2025

DOSAGE AND ADMINISTRATION:

Usual adult dose is 2 capsules by mouth daily once daily, or as prescribed by a licensed medical practitioner.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACIDOPHILUS LACTOBACILLUS - FDA Drug Approval Details